“Modifiable Hyperkalemia with Timely Recognition”- Beta Blocker (Metoprolol succinate) induced

Prasanth Prasad *

Department of General Medicine, Sree Gokulam Medical College and Research Foundation, India.

Sumesh Raj

Department of General Medicine, Sree Gokulam Medical College and Research Foundation, India.

*Author to whom correspondence should be addressed.


Abstract

This case report describes the very rarest possibility of drug induced hyperkalemia with beta blockers. In literature search only 2 cases were reported as metoprolol succinate induced hyperkalemia in diabetes patients without renal insufficiency. As per FDA reports  only 0.5 % patients have reported hyperkalemia induced by metoprolol [1]. Patient is diabetic and hypertensive. And she is on oral hypoglycemic agents, premixed insulin and on beta blockers along with calcium channel blocker. The potassium value was ranging from 6 to 6.7 mmol/l. Evaluated in detail and no other abnormalities noted in laboratory investigations. Once the offending drug metoprolol is withdrawn the potassium value reaches to normal range in very short period.

Keywords: Metoprolol succinate, hyperkalemia, betablocker induced


How to Cite

Prasad, Prasanth, and Sumesh Raj. 2022. “‘Modifiable Hyperkalemia With Timely Recognition’- Beta Blocker (Metoprolol Succinate) Induced”. Asian Journal of Research in Medical and Pharmaceutical Sciences 11 (3):12-14. https://doi.org/10.9734/ajrimps/2022/v11i330190.

Downloads

Download data is not yet available.